Pol I/II/III RPB8 Antibodies

Santa Cruz Biotechnology delivers a wide array of Pol I/II/III RPB8 monoclonal antibodies for research focused on RNA polymerases in transcription. Pol I/II/III RPB8 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RPB8 functions as a key component of RNA polymerases I, II, and III, which are essential for synthesizing ribosomal RNA and messenger RNA, as well as small nuclear RNAs. The proper functioning of RPB8 is vital for gene expression regulation and cellular processes, making it a significant target for studies related to transcriptional control and its implications in various diseases. Understanding the dynamics of RPB8 can provide insights into the mechanisms of transcription and its impact on cellular function. Researchers can explore the complex interactions between RPB8 and other transcriptional machinery components using specific detection methods. Investigating RPB8's role in different cell types and conditions helps reveal its significance in normal development and disease states. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of transcriptional regulation and its broader implications in human health.